Meningococcal disease and vaccination in college students

Neisseria meningitidis is a bacterial pathogen capable of causing rapidly progressing illness from nonspecific symptoms to end-organ failure or death in a matter of hours to days. Despite the availability of meningococcal vaccines, there remains a notable disease incidence peak among individuals age...

Full description

Saved in:
Bibliographic Details
Published in:Human vaccines & immunotherapeutics 2021-11, Vol.17 (11), p.4675-4688
Main Authors: Schaffer DeRoo, Sarah, Torres, Rachel G., Fu, Linda Y.
Format: Article
Language:English
Subjects:
college
Humans
Meningococcal Infections - epidemiology
Meningococcal Infections - prevention & control
Meningococcal Vaccines
Neisseria meningitidis
Review
Reviews
Students
United States - epidemiology
Vaccination
young adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53
cites cdi_FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53
container_end_page 4688
container_issue 11
container_start_page 4675
container_title Human vaccines & immunotherapeutics
container_volume 17
creator Schaffer DeRoo, Sarah
Torres, Rachel G.
Fu, Linda Y.
description Neisseria meningitidis is a bacterial pathogen capable of causing rapidly progressing illness from nonspecific symptoms to end-organ failure or death in a matter of hours to days. Despite the availability of meningococcal vaccines, there remains a notable disease incidence peak among individuals aged 18-19 years, with college students at increased risk for disease relative to non-college students. Between 2007 and 2017, as many as one in five colleges in the United States experienced an outbreak of meningococcal disease at their own or a nearby institution. Evidence-based strategies to promote meningococcal vaccination among students can be adapted for the college setting, but barriers exist that limit widespread implementation of these strategies by colleges. In this article, we review meningococcal disease characteristics and epidemiology among US college students, vaccination indications and coverage levels among US college students, as well as college vaccination policies and practices that can impact students' vaccine uptake.
doi_str_mv 10.1080/21645515.2021.1973881
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8828137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4c7924ebe5fd473cbdae252f0c3290bb</doaj_id><sourcerecordid>2580015706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53</originalsourceid><addsrcrecordid>eNp9kctuFDEQRVsIRKKQTwD1ks0MLj_a7g0CRTwiBbHJgp1V7S4Pjjx2sHuC8vd4mElENtTGpfKtc23drnsNbA3MsHccBqkUqDVnHNYwamEMPOtO9_OVUvLH88ce1El3XusNa6UZl8PwsjsRcgBhBnHajd8ohbTJLjuHsZ9DJazUY5r7O3QuJFxCTn1Ivcsx0ob6uuxmSkt91b3wGCudH8-z7vrzp-uLr6ur718uLz5erZwSclkpbwBHNiONEzBApf2gAQbjCAzTDuRkUGhJI6HXXJJUmqR3QILLhjjrLg_YOeONvS1hi-XeZgz27yCXjcWyBBfJSqfHBphI-Vlq4aZmyhX3zAk-smlqrPcH1u1u2tLs2jcKxifQpzcp_LSbfGeN4QaEboC3R0DJv3ZUF7sN1VGMmCjvquXKMAZKs6FJ1UHqSq61kH-0AWb3IdqHEO0-RHsMse29-feNj1sPkTXBh4MgJJ_LFn_nEme74H3MxRdMLlQr_u_xB1t1q_I</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580015706</pqid></control><display><type>article</type><title>Meningococcal disease and vaccination in college students</title><source>PubMed Central (Open Access)</source><creator>Schaffer DeRoo, Sarah ; Torres, Rachel G. ; Fu, Linda Y.</creator><creatorcontrib>Schaffer DeRoo, Sarah ; Torres, Rachel G. ; Fu, Linda Y.</creatorcontrib><description>Neisseria meningitidis is a bacterial pathogen capable of causing rapidly progressing illness from nonspecific symptoms to end-organ failure or death in a matter of hours to days. Despite the availability of meningococcal vaccines, there remains a notable disease incidence peak among individuals aged 18-19 years, with college students at increased risk for disease relative to non-college students. Between 2007 and 2017, as many as one in five colleges in the United States experienced an outbreak of meningococcal disease at their own or a nearby institution. Evidence-based strategies to promote meningococcal vaccination among students can be adapted for the college setting, but barriers exist that limit widespread implementation of these strategies by colleges. In this article, we review meningococcal disease characteristics and epidemiology among US college students, vaccination indications and coverage levels among US college students, as well as college vaccination policies and practices that can impact students' vaccine uptake.</description><identifier>ISSN: 2164-5515</identifier><identifier>ISSN: 2164-554X</identifier><identifier>EISSN: 2164-554X</identifier><identifier>DOI: 10.1080/21645515.2021.1973881</identifier><identifier>PMID: 34613863</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>college ; Humans ; Meningococcal Infections - epidemiology ; Meningococcal Infections - prevention &amp; control ; Meningococcal Vaccines ; Neisseria meningitidis ; Review ; Reviews ; Students ; United States - epidemiology ; Vaccination ; young adult</subject><ispartof>Human vaccines &amp; immunotherapeutics, 2021-11, Vol.17 (11), p.4675-4688</ispartof><rights>2021 Taylor &amp; Francis Group, LLC 2021</rights><rights>2021 Taylor &amp; Francis Group, LLC 2021 Taylor &amp; Francis</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53</citedby><cites>FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53</cites><orcidid>0000-0002-5649-5167</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828137/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828137/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34613863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schaffer DeRoo, Sarah</creatorcontrib><creatorcontrib>Torres, Rachel G.</creatorcontrib><creatorcontrib>Fu, Linda Y.</creatorcontrib><title>Meningococcal disease and vaccination in college students</title><title>Human vaccines &amp; immunotherapeutics</title><addtitle>Hum Vaccin Immunother</addtitle><description>Neisseria meningitidis is a bacterial pathogen capable of causing rapidly progressing illness from nonspecific symptoms to end-organ failure or death in a matter of hours to days. Despite the availability of meningococcal vaccines, there remains a notable disease incidence peak among individuals aged 18-19 years, with college students at increased risk for disease relative to non-college students. Between 2007 and 2017, as many as one in five colleges in the United States experienced an outbreak of meningococcal disease at their own or a nearby institution. Evidence-based strategies to promote meningococcal vaccination among students can be adapted for the college setting, but barriers exist that limit widespread implementation of these strategies by colleges. In this article, we review meningococcal disease characteristics and epidemiology among US college students, vaccination indications and coverage levels among US college students, as well as college vaccination policies and practices that can impact students' vaccine uptake.</description><subject>college</subject><subject>Humans</subject><subject>Meningococcal Infections - epidemiology</subject><subject>Meningococcal Infections - prevention &amp; control</subject><subject>Meningococcal Vaccines</subject><subject>Neisseria meningitidis</subject><subject>Review</subject><subject>Reviews</subject><subject>Students</subject><subject>United States - epidemiology</subject><subject>Vaccination</subject><subject>young adult</subject><issn>2164-5515</issn><issn>2164-554X</issn><issn>2164-554X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kctuFDEQRVsIRKKQTwD1ks0MLj_a7g0CRTwiBbHJgp1V7S4Pjjx2sHuC8vd4mElENtTGpfKtc23drnsNbA3MsHccBqkUqDVnHNYwamEMPOtO9_OVUvLH88ce1El3XusNa6UZl8PwsjsRcgBhBnHajd8ohbTJLjuHsZ9DJazUY5r7O3QuJFxCTn1Ivcsx0ob6uuxmSkt91b3wGCudH8-z7vrzp-uLr6ur718uLz5erZwSclkpbwBHNiONEzBApf2gAQbjCAzTDuRkUGhJI6HXXJJUmqR3QILLhjjrLg_YOeONvS1hi-XeZgz27yCXjcWyBBfJSqfHBphI-Vlq4aZmyhX3zAk-smlqrPcH1u1u2tLs2jcKxifQpzcp_LSbfGeN4QaEboC3R0DJv3ZUF7sN1VGMmCjvquXKMAZKs6FJ1UHqSq61kH-0AWb3IdqHEO0-RHsMse29-feNj1sPkTXBh4MgJJ_LFn_nEme74H3MxRdMLlQr_u_xB1t1q_I</recordid><startdate>20211102</startdate><enddate>20211102</enddate><creator>Schaffer DeRoo, Sarah</creator><creator>Torres, Rachel G.</creator><creator>Fu, Linda Y.</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5649-5167</orcidid></search><sort><creationdate>20211102</creationdate><title>Meningococcal disease and vaccination in college students</title><author>Schaffer DeRoo, Sarah ; Torres, Rachel G. ; Fu, Linda Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>college</topic><topic>Humans</topic><topic>Meningococcal Infections - epidemiology</topic><topic>Meningococcal Infections - prevention &amp; control</topic><topic>Meningococcal Vaccines</topic><topic>Neisseria meningitidis</topic><topic>Review</topic><topic>Reviews</topic><topic>Students</topic><topic>United States - epidemiology</topic><topic>Vaccination</topic><topic>young adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schaffer DeRoo, Sarah</creatorcontrib><creatorcontrib>Torres, Rachel G.</creatorcontrib><creatorcontrib>Fu, Linda Y.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (Open Access)</collection><jtitle>Human vaccines &amp; immunotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schaffer DeRoo, Sarah</au><au>Torres, Rachel G.</au><au>Fu, Linda Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meningococcal disease and vaccination in college students</atitle><jtitle>Human vaccines &amp; immunotherapeutics</jtitle><addtitle>Hum Vaccin Immunother</addtitle><date>2021-11-02</date><risdate>2021</risdate><volume>17</volume><issue>11</issue><spage>4675</spage><epage>4688</epage><pages>4675-4688</pages><issn>2164-5515</issn><issn>2164-554X</issn><eissn>2164-554X</eissn><abstract>Neisseria meningitidis is a bacterial pathogen capable of causing rapidly progressing illness from nonspecific symptoms to end-organ failure or death in a matter of hours to days. Despite the availability of meningococcal vaccines, there remains a notable disease incidence peak among individuals aged 18-19 years, with college students at increased risk for disease relative to non-college students. Between 2007 and 2017, as many as one in five colleges in the United States experienced an outbreak of meningococcal disease at their own or a nearby institution. Evidence-based strategies to promote meningococcal vaccination among students can be adapted for the college setting, but barriers exist that limit widespread implementation of these strategies by colleges. In this article, we review meningococcal disease characteristics and epidemiology among US college students, vaccination indications and coverage levels among US college students, as well as college vaccination policies and practices that can impact students' vaccine uptake.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>34613863</pmid><doi>10.1080/21645515.2021.1973881</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-5649-5167</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2164-5515
ispartof Human vaccines & immunotherapeutics, 2021-11, Vol.17 (11), p.4675-4688
issn 2164-5515
2164-554X
2164-554X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8828137
source PubMed Central (Open Access)
subjects college
Humans
Meningococcal Infections - epidemiology
Meningococcal Infections - prevention & control
Meningococcal Vaccines
Neisseria meningitidis
Review
Reviews
Students
United States - epidemiology
Vaccination
young adult
title Meningococcal disease and vaccination in college students
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A23%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meningococcal%20disease%20and%20vaccination%20in%20college%20students&rft.jtitle=Human%20vaccines%20&%20immunotherapeutics&rft.au=Schaffer%20DeRoo,%20Sarah&rft.date=2021-11-02&rft.volume=17&rft.issue=11&rft.spage=4675&rft.epage=4688&rft.pages=4675-4688&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.1080/21645515.2021.1973881&rft_dat=%3Cproquest_pubme%3E2580015706%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-5f81a90dae9b101a57f671168ce1807c14b8a374e9eaf724e457e4fc1e324c53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2580015706&rft_id=info:pmid/34613863&rfr_iscdi=true